tiprankstipranks
Trending News
More News >
Glenmark Pharmaceuticals Limited (IN:GLENMARK)
:GLENMARK
India Market

Glenmark Pharmaceuticals Limited (GLENMARK) Ratios

Compare
4 Followers

Glenmark Pharmaceuticals Limited Ratios

IN:GLENMARK's free cash flow for Q1 2026 was ₹0.42. For the 2026 fiscal year, IN:GLENMARK's free cash flow was decreased by ₹ and operating cash flow was ₹0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.65 1.56 1.28 1.28 1.96
Quick Ratio
1.17 1.01 0.84 0.84 1.37
Cash Ratio
0.38 0.29 0.28 0.28 0.29
Solvency Ratio
0.17 0.18 -0.14 -0.14 0.10
Operating Cash Flow Ratio
0.00 -0.14 -0.05 -0.05 0.12
Short-Term Operating Cash Flow Coverage
0.00 -0.49 -0.27 -0.27 1.26
Net Current Asset Value
₹ 20.33B₹ 20.95B₹ 9.17B₹ 9.17B₹ 3.41B
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.15 0.09 0.09 0.24
Debt-to-Equity Ratio
0.13 0.28 0.16 0.16 0.49
Debt-to-Capital Ratio
0.11 0.22 0.14 0.14 0.33
Long-Term Debt-to-Capital Ratio
0.05 0.05 0.00 0.00 0.29
Financial Leverage Ratio
1.98 1.81 1.83 1.83 2.04
Debt Service Coverage Ratio
3.53 0.96 -0.49 -0.49 0.79
Interest Coverage Ratio
10.14 20.20 1.22 1.22 4.77
Debt to Market Cap
0.02 0.05 0.04 0.04 0.33
Interest Debt Per Share
51.63 94.96 61.91 61.91 176.38
Net Debt to EBITDA
-0.57 0.35 -0.38 -0.38 2.75
Profitability Margins
Gross Profit Margin
51.54%66.14%27.59%27.59%64.35%
EBIT Margin
13.03%14.27%4.68%4.68%4.63%
EBITDA Margin
16.02%16.22%9.60%9.60%9.10%
Operating Profit Margin
14.38%31.31%5.34%5.34%13.10%
Pretax Profit Margin
9.78%10.47%0.31%0.31%6.82%
Net Profit Margin
6.49%7.84%-12.71%-12.71%2.34%
Continuous Operations Profit Margin
6.49%7.84%-15.50%-15.50%-0.70%
Net Income Per EBT
66.36%74.83%-4114.72%-4114.72%34.23%
EBT Per EBIT
68.00%33.44%5.78%5.78%52.09%
Return on Assets (ROA)
5.31%6.52%-10.46%-10.46%1.53%
Return on Equity (ROE)
11.31%11.83%-19.13%-19.13%3.14%
Return on Capital Employed (ROCE)
26.50%41.50%7.39%7.39%11.64%
Return on Invested Capital (ROIC)
16.89%26.41%-329.12%-329.12%4.86%
Return on Tangible Assets
5.87%7.18%-11.53%-11.53%1.75%
Earnings Yield
1.77%2.46%-5.42%-5.42%2.27%
Efficiency Ratios
Receivables Turnover
4.35 3.20 6.36 6.36 3.10
Payables Turnover
2.69 1.75 3.37 3.37 1.90
Inventory Turnover
2.42 1.38 3.40 3.40 1.52
Fixed Asset Turnover
4.01 3.46 3.34 3.34 2.54
Asset Turnover
0.86 0.83 0.82 0.82 0.66
Working Capital Turnover Ratio
7.30 5.41 3.27 3.67 3.02
Cash Conversion Cycle
104.30 170.80 56.44 56.44 164.70
Days of Sales Outstanding
86.48 114.20 57.42 57.42 117.56
Days of Inventory Outstanding
177.53 264.67 107.23 107.23 239.56
Days of Payables Outstanding
159.71 208.07 108.21 108.21 192.43
Operating Cycle
264.01 378.87 164.66 164.66 357.12
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 -29.33 -9.41 -9.41 22.16
Free Cash Flow Per Share
0.00 -55.89 -41.25 -41.25 0.62
CapEx Per Share
0.00 26.56 31.84 31.84 21.54
Free Cash Flow to Operating Cash Flow
0.00 1.91 4.38 4.38 0.03
Dividend Paid and CapEx Coverage Ratio
0.00 -1.01 -0.26 -0.26 0.84
Capital Expenditure Coverage Ratio
0.00 -1.10 -0.30 -0.30 1.03
Operating Cash Flow Coverage Ratio
0.00 -0.33 -0.22 -0.22 0.14
Operating Cash Flow to Sales Ratio
0.00 -0.06 -0.02 -0.02 0.05
Free Cash Flow Yield
0.00%-3.70%-4.20%-4.20%0.13%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
53.68 40.67 -18.46 -18.46 44.11
Price-to-Sales (P/S) Ratio
3.48 3.19 2.35 2.35 1.03
Price-to-Book (P/B) Ratio
5.97 4.81 3.53 3.53 1.38
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 -27.00 -23.82 -23.82 743.79
Price-to-Operating Cash Flow Ratio
0.00 -51.46 -104.43 -104.43 20.97
Price-to-Earnings Growth (PEG) Ratio
9.80 -0.26 0.03 0.03 -0.64
Price-to-Fair Value
5.97 4.81 3.53 3.53 1.38
Enterprise Value Multiple
21.21 20.00 24.06 24.06 14.07
Enterprise Value
557.54B 433.55B 272.94B 272.94B 162.97B
EV to EBITDA
22.27 20.00 24.06 24.06 14.07
EV to Sales
3.50 3.24 2.31 2.31 1.28
EV to Free Cash Flow
0.00 -27.49 -23.45 -23.45 924.42
EV to Operating Cash Flow
0.00 -52.39 -102.82 -102.82 26.06
Tangible Book Value Per Share
275.35 261.84 230.82 230.82 262.43
Shareholders’ Equity Per Share
339.54 313.60 278.14 278.14 335.75
Tax and Other Ratios
Effective Tax Rate
0.34 0.25 51.17 51.17 0.57
Revenue Per Share
581.42 473.56 418.66 418.66 450.99
Net Income Per Share
37.74 37.11 -53.22 -53.22 10.53
Tax Burden
0.66 0.75 -41.15 -41.15 0.34
Interest Burden
0.74 0.73 0.07 0.07 1.47
Research & Development to Revenue
0.06 0.07 0.10 0.10 0.10
SG&A to Revenue
0.05 0.23 0.02 0.02 0.02
Stock-Based Compensation to Revenue
>-0.01 >-0.01 <0.01 <0.01 <0.01
Income Quality
0.00 -0.59 0.18 0.18 0.72
Currency in INR